Oroxylin A might block the production of polypyrimidine tract-binding protein and increase the ratio of PKM1/PKM2 in HepG2 and SMMC-7721 hepatoma cells (Wei et al., 2017). The gene discussed is PKM; the disease is hepatocellular carcinoma.